On July 6, 2020, Anchiano Therapeutics Ltd. received notice from Danforth Advisors of its intention to terminate without cause its Consulting Agreement with the Company dated September 26, 2016   Pursuant to this agreement, Danforth Advisors has provided CFO services for the Company since May 5, 2020 and will no longer act in that role.   The Company has engaged Line Consulting A.S Ltd. ("Line Consulting") to provide all necessary financial consulting services and has appointed Mr. Andrew Fine as acting CFO. Line Consulting has provided financial consulting services for the Company since May 1, 2020. Danforth will continue to provide financial consulting services, including working with Line Consulting, for up to 60 days from the date of its notice.